Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment

Missak Haigentz, Dana M. Hartl, Carl E. Silver, Johannes A. Langendijk, Primož Strojan, Vinidh Paleri, Remco De Bree, Jean Pascal MacHiels, Marc Hamoir, Alessandra Rinaldo, Daniela Paccagnella, Ashok R. Shaha, Robert P. Takes, Alfio Ferlito

Research output: Contribution to journalReview article

28 Citations (Scopus)

Abstract

Distant metastases from head and neck squamous cell carcinoma (HNSCC), though rare at initial presentation, remain an important manifestation of cancer recurrence and mortality. Although generally considered incurable with a dismal prognosis despite palliative therapy, highly selected patients with distant metastases may have a long term survival benefit from aggressive surgery or radiotherapy. Advances in systemic treatments also may improve patient survival. This article reviews the current state of management of HNSCC patients with distant metastases.

Original languageEnglish (US)
Pages (from-to)787-793
Number of pages7
JournalOral Oncology
Volume48
Issue number9
DOIs
StatePublished - Sep 1 2012
Externally publishedYes

Fingerprint

Neoplasm Metastasis
Survival
Palliative Care
Radiotherapy
Therapeutics
Recurrence
Mortality
Carcinoma, squamous cell of head and neck
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oral Surgery
  • Oncology
  • Cancer Research

Cite this

Haigentz, M., Hartl, D. M., Silver, C. E., Langendijk, J. A., Strojan, P., Paleri, V., ... Ferlito, A. (2012). Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment. Oral Oncology, 48(9), 787-793. https://doi.org/10.1016/j.oraloncology.2012.03.019
Haigentz, Missak ; Hartl, Dana M. ; Silver, Carl E. ; Langendijk, Johannes A. ; Strojan, Primož ; Paleri, Vinidh ; De Bree, Remco ; MacHiels, Jean Pascal ; Hamoir, Marc ; Rinaldo, Alessandra ; Paccagnella, Daniela ; Shaha, Ashok R. ; Takes, Robert P. ; Ferlito, Alfio. / Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment. In: Oral Oncology. 2012 ; Vol. 48, No. 9. pp. 787-793.
@article{debcfa95ad3a4596ba1104a7a5cb1fcd,
title = "Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment",
abstract = "Distant metastases from head and neck squamous cell carcinoma (HNSCC), though rare at initial presentation, remain an important manifestation of cancer recurrence and mortality. Although generally considered incurable with a dismal prognosis despite palliative therapy, highly selected patients with distant metastases may have a long term survival benefit from aggressive surgery or radiotherapy. Advances in systemic treatments also may improve patient survival. This article reviews the current state of management of HNSCC patients with distant metastases.",
author = "Missak Haigentz and Hartl, {Dana M.} and Silver, {Carl E.} and Langendijk, {Johannes A.} and Primož Strojan and Vinidh Paleri and {De Bree}, Remco and MacHiels, {Jean Pascal} and Marc Hamoir and Alessandra Rinaldo and Daniela Paccagnella and Shaha, {Ashok R.} and Takes, {Robert P.} and Alfio Ferlito",
year = "2012",
month = "9",
day = "1",
doi = "10.1016/j.oraloncology.2012.03.019",
language = "English (US)",
volume = "48",
pages = "787--793",
journal = "Oral Oncology",
issn = "1368-8375",
publisher = "Elsevier Limited",
number = "9",

}

Haigentz, M, Hartl, DM, Silver, CE, Langendijk, JA, Strojan, P, Paleri, V, De Bree, R, MacHiels, JP, Hamoir, M, Rinaldo, A, Paccagnella, D, Shaha, AR, Takes, RP & Ferlito, A 2012, 'Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment', Oral Oncology, vol. 48, no. 9, pp. 787-793. https://doi.org/10.1016/j.oraloncology.2012.03.019

Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment. / Haigentz, Missak; Hartl, Dana M.; Silver, Carl E.; Langendijk, Johannes A.; Strojan, Primož; Paleri, Vinidh; De Bree, Remco; MacHiels, Jean Pascal; Hamoir, Marc; Rinaldo, Alessandra; Paccagnella, Daniela; Shaha, Ashok R.; Takes, Robert P.; Ferlito, Alfio.

In: Oral Oncology, Vol. 48, No. 9, 01.09.2012, p. 787-793.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment

AU - Haigentz, Missak

AU - Hartl, Dana M.

AU - Silver, Carl E.

AU - Langendijk, Johannes A.

AU - Strojan, Primož

AU - Paleri, Vinidh

AU - De Bree, Remco

AU - MacHiels, Jean Pascal

AU - Hamoir, Marc

AU - Rinaldo, Alessandra

AU - Paccagnella, Daniela

AU - Shaha, Ashok R.

AU - Takes, Robert P.

AU - Ferlito, Alfio

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Distant metastases from head and neck squamous cell carcinoma (HNSCC), though rare at initial presentation, remain an important manifestation of cancer recurrence and mortality. Although generally considered incurable with a dismal prognosis despite palliative therapy, highly selected patients with distant metastases may have a long term survival benefit from aggressive surgery or radiotherapy. Advances in systemic treatments also may improve patient survival. This article reviews the current state of management of HNSCC patients with distant metastases.

AB - Distant metastases from head and neck squamous cell carcinoma (HNSCC), though rare at initial presentation, remain an important manifestation of cancer recurrence and mortality. Although generally considered incurable with a dismal prognosis despite palliative therapy, highly selected patients with distant metastases may have a long term survival benefit from aggressive surgery or radiotherapy. Advances in systemic treatments also may improve patient survival. This article reviews the current state of management of HNSCC patients with distant metastases.

UR - http://www.scopus.com/inward/record.url?scp=84865174102&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865174102&partnerID=8YFLogxK

U2 - 10.1016/j.oraloncology.2012.03.019

DO - 10.1016/j.oraloncology.2012.03.019

M3 - Review article

C2 - 22516376

AN - SCOPUS:84865174102

VL - 48

SP - 787

EP - 793

JO - Oral Oncology

JF - Oral Oncology

SN - 1368-8375

IS - 9

ER -